Concepedia

Molly D. Congdon

MD

5

Publications

128

Citations

5

H-Index

2015

Active since

Affiliations

University of Virginia(Current)

Virginia Tech

Molly D. Congdon is an author at University of Virginia specializing in molecular pharmacology, drug discovery, and molecular modeling.

ORCID

Top concepts

Publications per year

2015–2022

5

Publications

5

Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels

Yugesh Kharel, Emily A. Morris, Molly D. Congdon et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 65 citations · Full text

Structure–Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors

Molly D. Congdon, Yugesh Kharel, Anne M. Brown et al. · ACS Medicinal Chemistry Letters · 2016 · 23 citations · Full text

Structure–activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors

Molly D. Congdon, Elizabeth S. Childress, Neeraj N. Patwardhan et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 17 citations · Full text

, , +8

Development of a GalNAc-Tyrosine-Specific Monoclonal Antibody and Detection of Tyrosine <i>O</i>-GalNAcylation in Numerous Human Tissues and Cell Lines

Xia Li, Tiffany R. Bellomo, Ruslan Gibadullin et al. · Journal of the American Chemical Society · 2022 · 13 citations · Full text

Extrachromosomal DNA amplicons in antimalarial‐resistant <i>Plasmodium falciparum</i>

Jennifer M. McDaniels, Adam C. Huckaby, Sabrina A. Carter et al. · Molecular Microbiology · 2020 · 10 citations · Full text

Rows per page

1–5 of 5